Inside Big Pharma's $70M Drug Pricing War In Calif.
Top pharmaceutical companies have earmarked nearly $70 million to defeat a high-stakes ballot measure that would cap prescription drug prices in California, and experts say the outcome will reverberate from coast...To view the full article, register now.
Already a subscriber? Click here to view full article